Flavonoids from the aerial parts of Houttuynia cordata attenuate lung inflammation in mice

다국어 초록 (Multilingual Abstract)

The aerial parts of Houttuynia cordata used for treating inflammation-related disorders contain flavonoids as major constituents. Since certain flavonoids possess antiinflammatory activity, especially in the lung, the pharmacological activities of H. cordata and the flavonoid constituents were evaluated using in vitro and in vivo models of lung inflammation. The 70 % ethanol extract of the aerial parts of H. cordata inhibited the production of inflammatory biomarkers IL-6 and NO in lung epithelial cells (A549) and alveolar macrophages (MH-S), respectively. And the same plant material, administered orally (100 and 400 mg/kg), significantly inhibited lung inflammatory response in a mouse model of lipopolysaccharide (LPS)-induced acute lung injury. From the extract, major flavonoids including afzelin, hyperoside and quercitrin were successfully isolated and they also attenuated LPS-induced lung inflammation in mice by oral administration. In particular, quercitrin showed most potent activity at 100 mg/kg. These results demonstrate for the first time that H. cordata and three flavonoid constituents have a therapeutic potential for treating lung inflammatory disorders.

참고문헌 (Reference)

1 Chen, J., "Total flavonoids of Mosla acabra leaves attenuate lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling n mice" 148 : 835-841, 2013

2 Lim, H.J., "The root barks of Morus alba and the flavonoid constituents inhibit airway inflammation" 149 : 169-175, 2013

3 Bae, K., "The medicinal plants of Korea" Kyo-Hak Publishing Company 160-, 2000

4 Kim, I.S., "The inhibitory effect of Houttuynia cordata extract on stem cell factor-induced HMC-1 cell migration" 112 : 90-95, 2007

5 Lu, H.M., "Tentative fingerprint-efficacy study of Houtuynia cordata injection in quality control of traditional Chinese medicine" 54 : 725-730, 2006

6 Lago, J.H.G., "Structureactivity association of flavonoids in lung diseases" 19 : 3570-3595, 2014

7 Mossman, T., "Rapid colorimetric assay for cellular growth and survival : application to proliferation and cytotoxic assays" 65 : 55-63, 1983

8 Ganesan, S., "Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression" 11 : 131-, 2010

9 Guan, Y., "Protective effects of liquiritigenin apioside on cigarette smoke-induced lung epithelial cell injury" 26 : 473-483, 2012

10 고현정, "Inhibition of Experimental Lung Inflammation and Bronchitis by Phytoformula Containing Broussonetia papyrifera and Lonicera japonica" 한국응용약물학회 19 (19): 324-330, 2011

11 Li, W., "Houttuynia cordata, a novel and selective COX-2 inhibitor with anti-inflammatory activity" 133 : 922-927, 2011

12 Barnes, P.J, "Cellular and molecular mechanisms of chronic obstructive pulmonary disease" 35 : 71-86, 2014

13 Kim, H.P., "Antiinflammatory plant flavonoids and cellular action mechanisms" 96 : 229-245, 2004

14 Lee, S.Y., "Antibacterial effects of afzelin isolated from Cornus macrophylla on Pseudomonas aeruginosa, a leading cause of illness in immunocompromised individuals" 19 : 3173-3180, 2014

15 Dajeong Kim, "Anti-inflammatory effects of Houttuynia cordata supercritical extract in carrageenan-air pouch inflammation model" 한국실험동물학회 28 (28): 137-140, 2012

16 Jiang Y., "Anti-complementary constituents of Houttuynia cordata and their targets in complement activation cascade" 28 : 407-410, 2014

17 Chun, J.M., "An ethyl acetate fraction derived from Houttynia cordata extract inhibit the production of inflammatory markers by suppressing NF-jB and MAPK activation in lipopolysaccharide-stimulated RAW264. 7 macrophages" 14 : 234-, 2014

18 Chapman, R.W, "A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation" 322 : 486-493, 2007

19 Kumar, M, "A current update on the phytopharmacological aspects of Houttuynia cordata Thunb" 8 : 22-35, 2014